Stoke Therapeutics, Inc. (STOK) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$11,532
Total Return
15.32%
CAGR
2.89%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.77% |
| Median | -0.48% |
| Best | +103.62% |
| Worst | -53.46% |
| % of Windows Positive | 49.1% |
1-Year (252 Trading Days)
| Average | +33.88% |
| Median | -17.22% |
| Best | +487.04% |
| Worst | -78.00% |
| % of Windows Positive | 42.7% |
3-Year (756 Trading Days)
| Average | +39.61% |
| Median | -37.76% |
| Best | +376.95% |
| Worst | -73.22% |
| % of Windows Positive | 34.2% |
Risk Metrics
| Maximum Drawdown | -91.80% |
| Average Drawdown | -60.10% |
| Drawdown Duration | 1221 Trading Days (Unrecovered) |
| Sortino Ratio | 0.67 |
| Calmar Ratio | 0.03 |
| CVaR (5%) | -10.07% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +12.19% (+46.02% ann.) | +$1219.29 | $0.00 | $0.00 | $0.00 |
| 2025 | +187.76% | +$18776.05 | $0.00 | $0.00 | $0.00 |
| 2024 | +109.70% | +$10969.57 | $0.00 | $0.00 | $0.00 |
| 2023 | -43.01% | $4301.19 | $0.00 | $0.00 | $0.00 |
| 2022 | -61.53% | $6152.56 | $0.00 | $0.00 | $0.00 |
| 2021 | -61.26% | $6126.27 | $0.00 | $0.00 | $0.00 |
| 2020 | +118.68% | +$11867.94 | $0.00 | $0.00 | $0.00 |
| 2019 partial | +10.75% (+21.09% ann.) | +$1075.48 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 19, 2019 – February 19, 2020 | +8.21% | +12.49% | +$821.28 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -27.84% | -97.59% | $2784.12 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +86.74% | +173.18% | +$8674.47 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -41.18% | -39.56% | $4118.06 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -57.19% | -59.37% | $5718.87 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +37.45% | +18.72% | +$3745.44 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +133.97% | +70.79% | +$13396.84 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.